News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Shortage of Registered Pathologists in India Continues to Put Patients at Risk in Illegal Labs that Defy Bombay Court Orders

Professional pathologist’s organization in Maharashtra, India, demands that the government’s Directorate of Medical Education and Research intensify enforcement of laws regulating clinical pathology labs, or suspend the director for failing to comply

There are thousands more medical laboratories in India than there are certified pathologists to supervise and direct them. This is becoming a source of conflict. On one side are consumers who want quality medical laboratory testing services they can trust and government regulators who want to enforce the law. On the other side are tens of thousands of lab companies that continue to operate without certified pathologists and other trained lab scientists.

This is why India continues its struggle to provide licensed and registered clinical pathology services to its more than 1.2 billion residents amid a sea of illegal pathology clinics and a government that seems increasingly ineffectual in its ability to protect patients. Frustrations with government organizations and law enforcement has led many professional pathology and microbiology organizations to speak out. (more…)

Two Different Research Teams Announce Tests for Alzheimer’s Disease That Could Be Useful for Clinical Laboratories after Clearance by the FDA

A university research team and a global diagnostics company simultaneously but independently unveil two new tests that accurately identify people predisposed to Alzheimer’s at earlier stages in the disease

Medical laboratory scientists and clinical pathologists have long awaited an accurate and clinically-useful test for the predisposition and early diagnosis of Alzheimer’s disease. Now comes pioneering efforts from two organizations that suggest real progress is being made.

One organization is an academic center and the other is an in vitro company. It was a research team at Rowan University School of Osteopathic Medicine (RowanSOM) that announced development of the first blood test to use the body’s own immune system to detect mild cognitive impairment (MCI), an early stage of Alzheimer’s disease.

Similarly, research scientists for Randox Laboratories unveiled to pathologists, clinical laboratory leaders, and others attending the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting, how their biochip-based technology also could be used to detect elevated risk for Alzheimer’s disease. (more…)

;